Haleon PLC (HLN) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.032x

Based on the latest financial reports, Haleon PLC (HLN) has a cash flow conversion efficiency ratio of 0.032x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX513.50 Million ≈ $62.48K USD) by net assets (GBX16.00 Billion ≈ $1.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Haleon PLC - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Haleon PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Haleon PLC debt and liabilities for a breakdown of total debt and financial obligations.

Haleon PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Haleon PLC ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Marshall Boya ve Vernik Sanayi AS
IS:MRSHL
-0.140x
TechTarget, Inc. Common Stock
NASDAQ:TTGT
-0.015x
Ningbo Heli Mould Technology Co Ltd Class A
SHG:603917
0.028x
Tarczynski S.A.
WAR:TAR
0.150x
Chalice Mining Limited
F:C8U
-0.100x
Saratoga Investment Corp
NYSE:SAR
0.018x
Bafang Yunji Intl Co Ltd
TW:2753
0.108x
Xuancheng Valin Precision Technology Co Ltd
SHG:603356
0.112x

Annual Cash Flow Conversion Efficiency for Haleon PLC (2019–2024)

The table below shows the annual cash flow conversion efficiency of Haleon PLC from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see Haleon PLC (HLN) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX16.22 Billion
≈ $1.97 Million
GBX2.30 Billion
≈ $279.97K
0.142x +12.98%
2023-12-31 GBX16.73 Billion
≈ $2.04 Million
GBX2.10 Billion
≈ $255.51K
0.126x +0.14%
2022-12-31 GBX16.46 Billion
≈ $2.00 Million
GBX2.06 Billion
≈ $251.01K
0.125x +144.80%
2021-12-31 GBX26.48 Billion
≈ $3.22 Million
GBX1.36 Billion
≈ $164.99K
0.051x -4.56%
2020-12-31 GBX26.22 Billion
≈ $3.19 Million
GBX1.41 Billion
≈ $171.19K
0.054x +87.12%
2019-12-31 GBX27.41 Billion
≈ $3.34 Million
GBX786.00 Million
≈ $95.63K
0.029x --

About Haleon PLC

LSE:HLN UK Drug Manufacturers - Specialty & Generic
Market Cap
$372.86 Million
GBX3.06 Trillion GBX
Market Cap Rank
#14010 Global
#65 in UK
Share Price
GBX344.10
Change (1 day)
+1.21%
52-Week Range
GBX326.60 - GBX415.20
All Time High
GBX415.20
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more